Harvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...

The S&P 500 and Nasdaq hit record closing highs as hopes of a US Iran ceasefire extension boosted sentiment. Investors also digested US inf...

In a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...

Alphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. ...

The new deal builds on existing collaborations between the two companies, which struck a software licensing agreement in 2023, according to...

Eli Lilly & Company declined the applications on both the occasion, citing the reason that it is really challenging for them to sign volunt...

Baricitinib has received restricted emergency use approval, for use in combination with Remdesivir, for treatment of suspected or laborator...

The company has issued additional royalty-free, non-exclusive voluntary licences to Dr Reddy's, MSN Laboratories and Torrent Pharmaceutical...

The Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company fo...

According to the agreement, Lupin will market and sell Eglucent through its own specialty field force while Lilly will be responsible for m...

Agila Specialties will manufacture the cancer medicines, and Lilly will register and market them in geographies across the emerging markets...

Pharma company Jubilant Organosys has extended its four-year-old drug research collaboration with Eli Lilly for another five years.

Zydus Cadila eyes large chunk of revenue generation from its new drug discovery pact with global drug giant Eli Lilly.

Shares of Glenmark Pharma plunged 20 per cent after it announced that its partner Eli Lilly has suspended further clinical development for ...

Encouraged by the introduction of the product patent regime, US-based Eli Lilly & Company is planning to introduce a range of new drugs in ...

Pharma major Nicholas Piramal India Ltd (NPIL) will develop and commercialise a select group of US-based Eli Lilly and Company's pre-clinic...

Suven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research f...